CompletedNot Applicable

Endosponge Vacuum Therapy (E-VAC) Registry of Intestinal Anastomotic Leaks and Perforations

United States65 participantsStarted 2014-11-01

Plain-language summary

The purpose of this registry is to collect data on the clinical use of endoluminal vacuum (E-Vac) therapy to treat both upper and lower intestinal leaks and perforations.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All patients undergoing E-Vac Therapy * Age \> 17 years Exclusion Criteria: * 17 years of age or younger * Undergone an E-Vac placement \> 14 days before consenting

What they're measuring

In-Hospital survival-rate

Timeframe: 6 months

Trial details

NCT IDNCT02477930

SponsorBaylor Research Institute

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-09-21

View on ClinicalTrials.gov More Intestinal Anastomotic Leak trials